Applied BioCode, Inc. Announces Strategic Technology Partnership, License Agreement with EraGen Biosciences Inc.

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, Inc. and EraGen Biosciences Inc. today announced that they have entered into a strategic partnership and license agreement. The agreement provides EraGen with access to Applied BioCode's Barcoded Magnetic Bead technology and the CE-marked BioCode-1000 system. The technology provides a robust and reliable solution for development and clinical laboratory use of multiplexed infectious disease and genetic tests.

Back to news